Lack of new drugs is reaching crisis point, says reviewBMJ 2003; 326 doi: https://doi.org/10.1136/bmj.326.7381.119 (Published 18 January 2003) Cite this as: BMJ 2003;326:119
- Roger Dobson
The number of new drugs approved in the United States last year fell to half the annual average over the past five years.
Only 15 new drugs were approved by the Food and Drug Administration in 2002, compared with a five year annual average of 31, says an editorial in Nature Reviews Drug Discovery (2003:2:3).
It warns that the fall in the number of new drugs is reaching crisis point and says that new drug applications are down worldwide.
It says that the European parliament's environment committee has asked Thomas Lonngren, executive director of …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial